September 27, 2016 3:02 PM ET


Company Overview of Dipexium Pharmaceuticals, Inc.

Executive Profile

Jack Hugh Dean Ph.D., Sc.D. (Hon.), DABT, Fellow ATS

Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee, Dipexium Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships


Dr. Jack Hugh Dean, Ph.D., Sc.D. (Hon.), DABT, Fellow ATS is an advisor to the Executive Vice President of Drug Development for Sanofi-Aventis, a consultant on drug development strategy, drug safety issues and immunotoxicology through Drug Development Advisors, LLC. Dr. Dean is a Research Professor in the departments of Medical Pharmacology and Pharmacology/Toxicology, Colleges of Medicine and Pharmacy, at University of Arizona in Tucson. Dr. Dean served as the President, ...

Corporate Headquarters

14 Wall Street
New York, New York 10005

United States

Phone: 212-269-2834
Fax: 212-269-2580

Board Members Memberships

Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee


PhD 1972
The University of Arizona
California State University, Long Beach
California State University, Long Beach

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$26,550
Total Calculated Compensation$26,550

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Dipexium Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at